HIGH CONTAINMENT: OUR DAILY CHALLANGE
One of the goals that our company has set itself since its inception is to encourage improvements in safety and health of operators at work, and to guarantee the quality of products.
This is the reason why SteriValves has been one of the first company to realize the high containment valve splitvalve (Sterisplit).
During these years our company has been keeping on working on research and development to propose a valve able to handle highly potent active Ingredients with an increasing level of security.
Our R&D dept. constantly looks for the maximum safe exposure level: the occupational exposure limit (OEL).
In 2008 Vega (an independent occupational hygiene consultancy located in the North East of England) certified our valeve Sterisplit ND100mm for max containment achieved:0,37µg/m3.
That recognition confirmed that we were moving in the right direction and our commitment since then has grown.
We understood that there are no universal solutions, every situation has its own answer, every plant its specific project features.
Product and process are not always exactly the same (even for the same final drug), and it is not correct to talk about a single split valve.
Guidelines are fundamental but not enough, we use to exchange knowledge with our customers and our experience to propose the high containment valve suited to the specific process.
On June 25 in Milan we participated at the ISPE Forum Day ’Containment in the manufacture of highly potent APIs and Dosage Forms’.
It has been a precious opportunity to meet people who, like us, see in research on containment an opportunity to raise the level of health and safety of the operators and to guarantee an excellent level of the quality of pharmaceutical and chemical products intended for all patients.